Enhanced susceptibility to immune nephritis in DBA/1 mice is contingent upon IL-1 expression

Clinical Immunology

Volumn 124, Issue 1, 2007, Pages 49-56

  Xie, Chun ^a   Qin, Xiangmei ^a   Jonnala, Geetha ^a   Gong, Yimei ^a   Yan, Mei ^a   Zong, Peijun ^a   Zhou, Xin J ^a   Mohan, Chandra ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

DBA 1; Genetics; IL 1; Lupus

Indexed keywords

INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR; UREA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE PREDISPOSITION; FEMALE; GLOMERULONEPHRITIS; IMMUNE COMPLEX NEPHRITIS; INTERSTITIAL NEPHRITIS; MALE; MOUSE; MOUSE STRAIN; MULTIPLE ORGAN FAILURE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROVOCATION TEST; WILD TYPE;

ANIMALS; BIOLOGICAL MARKERS; BLOOD UREA NITROGEN; DISEASE SUSCEPTIBILITY; FEMALE; GLOMERULONEPHRITIS; INTERLEUKIN-1; MALE; MICE; MICE, INBRED DBA; MICE, KNOCKOUT; PROTEINURIA; SPECIES SPECIFICITY; UREMIA;

EID: 34250774083     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2007.04.002     Document Type: Article

References (50)

1. Masugi M. Glomerulonephritis durch das spezifische antinierenserum: ein Beitrag zur Pathogenese der diffusen Glomerulonephritis. Beitr. Pathol. Anat. Allg. Pathol. 92 (1934) 429
2. Le M.H., Haas C., Marino M., and Ryffel B. Prevention of crescentic glomerulonephritis induced by anti-glomerular membrane antibody in tumor necrosis factor-deficient mice. Lab. Invest. 78 (1998) 1625-1631
3. Suzuki Y., Shirato I., Okumura K., Ravetch J.V., Takai T., Tomino Y., and Ra C. Distinct contribution of Fc receptors and angiotensin II-dependent pathways in anti-GBM glomerulonephritis. Kidney Int. 54 (1998) 1166-1174
4. Tesch G.H., Schwarting A., Kinoshita K., Lan H.Y., Rollins B.J., and Kelley V.R. Monocyte chemoattractant protein-1 promotes macrophage-mediated tubular injury, but not glomerular injury, in nephrotoxic serum nephritis. J. Clin. Invest. 103 (1999) 73-80
5. Topham P.S., Csizmadia V., Soler D., Hines D., Gerard C.J., Salant D.J., and Hancock W.W. Lack of chemokine receptor CCR1 enhances Th1 responses and glomerular injury during nephrotoxic nephritis. J. Clin. Invest. 104 (1999) 1549-1557
6. Janssen U., Ostendorf T., Gaertner S., Eitner F., Hedrich H.J., Assmann K.J., and Floege J. Improved survival and amelioration of nephrotoxic nephritis in intercellular adhesion molecule-1 knockout mice. J. Am. Soc. Nephrol. 9 (1998) 1805-1814
7. Sheerin N.S., Springall T., Carroll M.C., Hartley B., and Sacks S.H. Protection against anti-glomerular basement membrane (GBM)-mediated nephritis in C3- and C4-deficient mice. Clin. Exp. Immunol. 110 (1997) 403-409
8. Tang T., Rosenkranz A., Assmann K.J., Goodman M.J., Gutierrez-Ramos J.C., Carroll M.C., Cotran R.S., and Mayadas T.N. A role for Mac-1 (CDIIb/CD18) in immune complex-stimulated neutrophil function in vivo: Mac-1 deficiency abrogates sustained Fcgamma receptor-dependent neutrophil adhesion and complement-dependent proteinuria in acute glomerulonephritis. J. Exp. Med. 186 (1997) 1853-1863
9. Mayadas T.N., Mendrick D.L., Brady H.R., Tang T., Papayianni A., Assmann K.J., Wagner D.D., Hynes R.O., and Cotran R.S. Acute passive anti-glomerular basement membrane nephritis in P-selectin-deficient mice. Kidney Int. 49 (1996) 1342-1349
10. Hebert M.J., Takano T., Papayianni A., Rennke H.G., Minto A., Salant D.J., Carroll M.C., and Brady H.R. Acute nephrotoxic serum nephritis in complement knockout mice: relative roles of the classical and alternate pathways in neutrophil recruitment and proteinuria. Nephrol. Dial. Transplant. 13 (1998) 2799-2803
11. Xie C., Zhou X.J., Liu X., and Mohan C. Enhanced susceptibility to end-organ disease in the lupus-facilitating NZW mouse strain. Arthritis Rheum. 48 (2003) 1080-1092
12. Xie C., Sharma R., Wang H., Zhou X.J., and Mohan C. Strain distribution pattern of susceptibility to immune-mediated nephritis. J. Immunol. 172 (2004) 5047-5055
13. Courtenay J.S., Dallman M.J., Dayan A.D., Martin A., and Mosedale B. Immunisation against heterologous type II collagen induces arthritis in mice. Nature 283 (1980) 666-668
14. Haqqi T.M., Qu X.M., Sy M.S., and Banerjee S. Restricted expression of T cell receptor V beta and lymphokine genes in arthritic joints of a TCR V beta a (H-2q) mouse strain-BUB/BnJ-with collagen-induced arthritis. Autoimmunity 20 (1995) 163-170
15. McIndoe R.A., Bohlman B., Chi E., Schuster E., Lindhardt M., and Hood L. Localization of non-Mhc collagen-induced arthritis susceptibility loci in DBA/1j mice. Proc. Natl. Acad. Sci. U. S. A. 96 (1999) 2210-2214
16. Enghard P., Langnickel D., and Riemekasten G. T cell cytokine imbalance towards production of IFN-gamma and IL-10 in NZB/W F1 lupus-prone mice is associated with autoantibody levels and nephritis. Scand. J. Rheumatol. 35 (2006) 209-216
17. Reilly C.M., Olgun S., Goodwin D., Gogal Jr. R.M., Santo A., Romesburg J.W., Ahmed S.A., and Gilkeson G.S. Interferon regulatory factor-1 gene deletion decreases glomerulonephritis in MRL/lpr mice. Eur. J. Immunol. 36 (2006) 1296-1308
18. Kitching A.R., Turner A.L., Wilson G.R., Semple T., Odobasic D., Timoshanko J.R., O'Sullivan K.M., Tipping P.G., Takeda K., Akira S., and Holdsworth S.R. IL-12p40 and IL-18 in crescentic glomerulonephritis: IL-12p40 is the key Th1-defining cytokine chain, whereas IL-18 promotes local inflammation and leukocyte recruitment. J. Am. Soc. Nephrol. 16 (2005) 2023-2033
19. Fukatsu A., Matsuo S., Tamai H., Sakamoto N., Matsuda T., and Hirano T. Distribution of interleukin-6 in normal and diseased human kidney. Lab. Invest. 65 (1991) 61-66
20. Horii Y., Iwano M., Hirata E., Shiiki M., Fujii Y., Dohi K., and Ishikawa H. Role of interleukin-6 in the progression of mesangial proliferative glomerulonephritis. Kidney Int., Suppl. 39 (1993) S71-S75
21. Okada H., Konishi K., Nakazato Y., Kanno Y., Suzuki H., Sakaguchi H., and Saruta T. Interleukin-4 expression in mesangial proliferative glomerulonephritis. Am. J. Kidney Dis. 23 (1994) 242-246
22. Sekikawa T., Kashihara N., Maruyama K., Satoh M., Okamoto K., Kanao K., Maeshima Y., Sugiyama H., Yamasaki Y., and Makino H. Expression of interleukin-8 in human glomerulonephritis. Res. Commun. Mol. Pathol. Pharmacol. 99 (1998) 217-224
23. Iwano M., Akai Y., Fujii Y., Dohi Y., Matsumura N., and Dohi K. Intraglomerular expression of transforming growth factor-beta 1 (TGF-beta 1) mRNA in patients with glomerulonephritis: quantitative analysis by competitive polymerase chain reaction. Clin. Exp. Immunol. 97 (1994) 309-314
24. Atkins R.C., Nikolic-Paterson D.J., Song Q., and Lan H.Y. Modulators of crescentic glomerulonephritis. J. Am. Soc. Nephrol. 7 (1996) 2271-2278
25. Kluth D.C., and Rees A.J. New approaches to modify glomerular inflammation. J. Nephrol. 12 (1999) 66-75
26. Iwakura Y. Roles of IL-1 in the development of rheumatoid arthritis: consideration from mouse models. Cytokine Growth Factor Rev. 13 (2002) 341-355
27. Kay J., and Calabrese L. The role of interleukin-1 in the pathogenesis of rheumatoid arthritis. Rheumatology (Oxford) 43 Suppl. 3 (2004) iii2-iii9
28. Waldherr R., Noronha I.L., Niemir Z., Kruger C., Stein H., and Stumm G. Expression of cytokines and growth factors in human glomerulonephritides. Pediatr. Nephrol. 7 (1993) 471-478
29. Noronha I.L., Kruger C., Andrassy K., Ritz E., and Waldherr R. In situ production of TNF-alpha, IL-1 beta and IL-2R in ANCA-positive glomerulonephritis. Kidney Int. 43 (1993) 682-692
30. Niemir Z.I., Stein H., Dworacki G., Mundel P., Koehl N., Koch B., Autschbach F., Andrassy K., Ritz E., Waldherr R., and Otto H.F. Podocytes are the major source of IL-1 alpha and IL-1 beta in human glomerulonephritides. Kidney Int. 52 (1997) 393-403
31. Cook H.T., Avey C., and Taylor G.M. Interleukin-1 beta gene expression in experimental glomerulonephritis in the rat: an in-situ hybridization study. Int. J. Exp. Pathol. 75 (1994) 157-163
32. Jenkins D.A., Wojtacha D.R., Swan P., Fleming S., and Cumming A.D. Intrarenal localization of interleukin-1 beta mRNA in crescentic glomerulonephritis. Nephrol. Dial. Transplant. 9 (1994) 1228-1233
33. Tesch G.H., Yang N., Yu H., Lan H.Y., Foti R., Chadban S.J., Atkins R.C., and Nikolic-Paterson D.J. Intrinsic renal cells are the major source of interleukin-1 beta synthesis in normal and diseased rat kidney. Nephrol. Dial. Transplant. 12 (1997) 1109-1115
34. Werber H.I., Emancipator S.N., Tykocinski M.L., and Sedor J.R. The interleukin 1 gene is expressed by rat glomerular mesangial cells and is augmented in immune complex glomerulonephritis. J. Immunol. 138 (1987) 3207-3212
35. Janeway C.A., Travers P., Walport M., and Shlomchik M.J. Immunobiology-the immune system in health and disease. 6th ed. (2005), Garland Science Publishing 78
36. Baranzini S.E., Laxer K., Bollen A., and Oksenberg J.R. Gene expression analysis reveals altered brain transcription of glutamate receptors and inflammatory genes in a patient with chronic focal (Rasmussen's) encephalitis. J. Neuroimmunol. 128 (2002) 9-15
37. Honda T., Domon H., Okui T., Kajita K., Amanuma R., and Yamazaki K. Balance of inflammatory response in stable gingivitis and progressive periodontitis lesions. Clin. Exp. Immunol. 144 (2006) 35-40
38. Lovell D.J., Bowyer S.L., and Solinger A.M. Interleukin-1 blockade by anakinra improves clinical symptoms in patients with neonatal-onset multisystem inflammatory disease. Arthritis Rheum. 52 (2005) 1283-1286
39. Janssen R., Verhard E., Lankester A., Ten Cate R., and van Dissel J.T. Enhanced interleukin-1beta and interleukin-18 release in a patient with chronic infantile neurologic, cutaneous, articular syndrome. Arthritis Rheum. 50 (2004) 3329-3333
40. Razumov S.V., Medvedev A.A., Chirun N.V., Sivkov A.V., Oshchepkov V.N., and Siniukhin V.N. Role of cytokines in the diagnosis of chronic prostatitis. Urologiia 6 (2003) 25-28
41. Pascual V., Allantaz F., Arce E., Punaro M., and Banchereau J. Role of interleukin-1 (IL-1) in the pathogenesis of systemic onset juvenile idiopathic arthritis and clinical response to IL-1 blockade. J. Exp. Med. 201 (2005) 1479-1486
42. Timoshanko J.R., Kitching A.R., Iwakara Y., Holdsworth S.R., and Tipping P.G. Contributions of IL-1 beta and IL-1alpha to crescentic glomerulonephritis in mice. J. Am. Soc. Nephrol. 15 (2004) 910-918
43. Zhou X.J., Laszik Z., Wang X.Q., Silva F.G., and Vaziri N.D. Association of renal injury with increased oxygen free radical activity and altered nitric oxide metabolism in chronic experimental hemosiderosis. Lab. Invest. 80 (2000) 1905-1914
44. Tipping P.G., and Kitching A.R. Glomerulonephritis, Th1 and Th2: what's new?. Clin. Exp. Immunol. 142 (2005) 207-215
45. Palmer G., Talabot-Ayer D., Szalay-Quinodoz I., Marte M., Arend W.P., and Gabay C. Mice transgenic for intracellular interleukin-1 receptor antagonist type 1 are protected from collagen-induced arthritis. Eur. J. Immunol. 33 (2003) 434-440
46. Brennan D.C., Yui M.A., Wuthrich R.P., and Kelley V.E. Tumor necrosis factor and IL-1 in New Zealand Black/White mice. Enhanced gene expression and acceleration of renal injury. J. Immunol. 143 (1989) 3470-3475
47. Schorlemmer H.U., Kanzy E.J., Langner K.D., and Kurrle R. Immunoregulation for SLE-like disease by the IL-1 receptor: disease modifying activity on BDF1 hybrid mice and MRL autoimmune mice. Agents Action 39 (1993) C117-C120
48. Kiberd B.A., and Stadnyk A.W. Established murine lupus nephritis does not respond to exogenous interleukin 1 receptor antagonist; a role for the endogenous molecule?. Immunopharmacology 30 (1995) 131-137
49. Lan H.Y., Nikolic-Paterson D.J., Zarama M., Vannice J.L., and Atkins R.C. Suppression of experimental crescentic glomerulonephritis by the interleukin-1 receptor antagonist. Kidney Int. 43 (1993) 479-485
50. Lan H.Y., Nikolic-Paterson D.J., Mu W., Vannice J.L., and Atkins R.C. Interleukin-1 receptor antagonist halts the progression of established crescentic glomerulonephritis in the rat. Kidney Int. 47 (1995) 1303-1309